Skip to Content

REV 20 mg (Revlimid 20 mg)

Generic Name: lenalidomide

Pill with imprint REV 20 mg is Blue / Green, Capsule-shape and has been identified as Revlimid 20 mg. It is supplied by Celgene Corporation.

Revlimid is used in the treatment of multiple myeloma; lymphoma; follicular lymphoma; myelodysplastic diseases; mantle cell lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for REV 20 mg

Revlimid 20 mg REV 20 mg

Revlimid

Generic Name
lenalidomide
Imprint
REV 20 mg
Strength
20 mg
Color
Blue / Green
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
59572-0420

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.